WorldLink

Sales and Operations Planning

Objective

Improve on the current sales forecast process, to

  • support robust top-line business planning,
  • reduce forecast/ prediction errors at lower granularities and,
  • exhibit capability of AutoML solutions to scale the process across customer/  channel segments.

Industry: Healthcare – Wholesaler

Services: Technology Innovation

Technology: Sales Forecasting

Enabled daily sales forecasting cadence (vs. monthly cadence) resulting in improved visibility and actionable insights into month-end sales performance.

Reduced forecasting error by

$16B

per year with baseline dataset

Reduced forecast/prediction errors on ‘problematic’ drug categories – e.g. bio-similar, seasonal or new products.

Our Client

Our client is a Fortune 100 global healthcare wholesaler and one of the largest drug distributor in the U.S., supplying a wide range of pharmaceuticals, as well as medical supplies and equipment.

Challenge

Pharmaceuticals sales forecasting is a complex process, influenced not only by interdependence between entities within the value chain/ecosystem, but also human health trends, seasonality, epidemics, manufacturers’ competitive programs, BRx to GRx conversions, active pharma ingredient relationships & regulation.

Approach

AutoML solutions employed against:

  • Enterprise sales data by strategic owner/channel and profit-center/ material-product.
Current State Challenges and Future State Vision

Outcomes

  • Improved sales forecasting system delivers:

    • Robust performance projections & associated financial plans
    • Improved inventory planning and stock replenishment decisions
    • Informs design of manufacturer rebate strategy and rebate program management
    • Decreases customer revenue leakage

Impact

    • Enabled daily sales forecasting cadence (vs. currently monthly cadence) resulting in improved visibility to and actionability on month-end sales performance
    • Scaled forecasting capabilities across customers and channels
    • Reduced forecasting error by $16 billion per year with baseline dataset*
    • Reduced forecast/prediction errors on ‘problematic’ drug categories – e.g. bio-similar, seasonal or new products

    *Dataset with strategic owners, profit centers, date features and without knowledge of external influencing factors (e.g. acquisitions), business dynamics, contracts re-negotiation, pricing, etc.

Enjoy this story? Share it to your network.

View more Case Studies

Empowering Operational Efficiency With GenAI

risk

Issues (Risk) Correlation & Consolidation Analysis

Hybrid Cloud Analytics

Ready to transform your business?

Explore Our Services and Unleash Your Potential Today!

Ready to transform your business?

Explore Our Services and Unleash Your Potential Today!

Let's work together!

3880 PARKWOOD BLVD
BUILDING 2
FRISCO, TX 75034

800.673.6155

info@worldlink-us.com